• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PLRX

PLRX

Pliant Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.18

+0.02 (+1.72%)

Rating:C+

Company Profile

CEO

Bernard Coulie

IPO Date

2020-06-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.18

Prev. Close

$1.16

Day Low

$1.14

Day High

$1.20

52W Low

$1.09

52W High

$1.95

Market Cap

$0.07B

Volume

1.59M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

5

Avg Positive

30.6%

Avg Negative

1.2%

Avg Neutral

68.2%

News Feed

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/10/2021·↑ positive

Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

GlobeNewsWire·5/5/2021·↑ positive

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewsWire·3/16/2021·↑ positive

Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner

GlobeNewsWire·3/16/2021·↑ positive

Pliant Therapeutics: An Early Stage Company With Important Collaborations

Seeking Alpha·11/23/2020·↑ positive